http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2216912-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 |
| filingDate | 2000-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d2aec2967dc8640842ca1ce281d120f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb64b2a0924c58b56af30206d3a31576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f430a1256896573a661be162e57694e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03697e8275006b66c72838bab1d8994a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b3218b4d5fe66870dc342b79152843f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc17e0a88ce6cdc8dd6bec06734e209d |
| publicationDate | 2004-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2216912-T3 |
| titleOfInvention | USEFUL BISPIDINE COMPOUNDS IN THE TREATMENT OF CARDIAC ARRITMIES. |
| abstract | A compound of formula I where R1 represents C1-12 alkyl, X represents O; R5a and R5b independently represent H or C1-3 alkyl; R2 and R3 independently represent H, C1-4 alkyl (substituted and / or optionally terminated with one or more nitro or cyano groups), OR7, N (R7a) R7b, OC (O) R8 or together form -O- (CH2) 2-O-, - (CH2) 3-, - (CH2) 4- or - (CH2) 5-; R7 and R8 independently represent H, C1-6 alkyl or - (CH2) b-phenyl (whose last two groups are optionally substituted and / or terminated with one or more substituents selected from -OH, halo, cyano, nitro, C1- alkyl 4 and / or C1-4 alkoxy); R7a and R7b independently represent H or C1-6 alkyl; b represents 0, 1, 2, 3 or 4; R4 represents H or C1-6 alkyl; D represents H, C1-4 alkyl, -OH, or - (CH2) cN (R10) - (R11); c represents 0, 1, 2, 3 or 4; R10 represents H, C1-6 alkyl, - (CH2) d-phenyl, -C (NH) NH2, -S (O) 2R13, - [C (O)] eN (R14) (R15), -C (O ) R16 or -C (O) OR17; e represents 1 or 2; R11 represents H, C1-6 alkyl, -C (O) R18 or -C (CH2) f-phenyl (said last group being optionally substituted and / or terminated (as appropriate) with one or more substituents selected from -OH, cyano, halo, amino, nitro, C1-6 alkyl and / or C1-6 alkoxy); R14, R15, R16, R17 and R18 independently represent H, C1-6 alkyl, Het2 or - (CH2) g-aryl (whose last three groups are optionally substituted and / or terminated (as appropriate) with one or more selected substituents of -OH, cyano, halo, amino, nitro, C1-6 alkyl and / or C1-6 alkoxy); R13 represents C1-6 alkyl, aryl or - (CH2) h-phenyl (all of which are optionally substituted and / or terminated (as appropriate) with one or more substituents selected from halo, nitro, C1-6 alkyl and / or C1-6 alkoxy). |
| priorityDate | 1999-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 157.